Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting

BACKGROUND: Diverging approaches towards market entry and uptake of biosimilars, even within a country, leads to regional variation in biosimilar use. This is the case in Sweden, where the 21 county councils control the healthcare budget and offer regional guidance. OBJECTIVES: This study aimed to a...

Full description

Saved in:
Bibliographic Details
Published in:BioDrugs
Main Authors: Moorkens, Evelien, Simoens, Steven, Troein, Per, Declerck, Paul, Vulto, Arnold G., Huys, Isabelle
Format: Artigo
Language:Inglês
Published: Springer International Publishing 2019
Subjects:
Original Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6533216/
https://ncbi.nlm.nih.gov/pubmed/30945206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00346-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items